Literature DB >> 30279745

Interesting electrophysiological findings in a patient with coexistence of atrial tachycardia originating from coronary sinus and slow-fast atrioventricular nodal reentrant tachycardia.

Kyoichiro Yazaki1, Kenji Enta1, Shohei Kataoka1, Mitsuru Kahata1, Asako Kumagai1, Koji Inoue1, Hiroshi Koganei1, Masato Otsuka1, Yasuhiro Ishii1.   

Abstract

Slow-fast atrioventricular nodal tachycardia (AVNRT) has various electrophysiological aspects due to atrioventricular (AV) nodal physiology. In addition, concomitantly another form of arrhythmia with AVNRT, especially atrial tachycardia (AT), was an infrequent arrhythmia. A 38-year-old female with narrow QRS tachycardia underwent electrophysiological study due to frequent faintness. The electrophysiological study disclosed the coexistence of AT originating from coronary sinus (CS) with slow-fast AVNRT. We easily diagnosed AT originating from CS and terminated with several radiofrequency ablations (RFA) around CS. The diagnosis of slow-fast AVNRT, however, was somewhat difficult due to the following findings: (1) small amount of adenosine triphosphate (ATP) could terminate slow-fast AVNRT reproducibly; (2) we could provoke slow-fast AVNRT only by RV pacing with isoproterenol infusion. With other electrophysiological findings, we diagnosed slow-fast AVNRT. Radiofrequency energy was delivered initially in the posteroseptal region, followed by inside CS, and finally in the middle septal region, which completed the slow pathway ablation. After the procedure, we could never provoke these arrhythmias. <Learning objective: Coexistence of focal AT originating from CS with slow-fast AVNRT is a rare phenomenon. Furthermore, slow-fast AVNRT could show unusual characteristic as following: (1) small amount of ATP terminates slow-fast AVNRT; (2) atrial pacing never provoked slow-fast AVNRT with isoproterenol infusion whereas ventricular pacing did, which depends on the physiological characteristic of the dual AV nodal pathway. Accordingly, we should precisely assess the obtained electrophysiological findings.>.

Entities:  

Keywords:  Adenosine triphosphate; Atrial tachycardia; Atrioventricular nodal reentrant tachycardia; Coronary sinus; Effective refractory period

Year:  2016        PMID: 30279745      PMCID: PMC6135007          DOI: 10.1016/j.jccase.2016.10.014

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group.

Authors:  J P DiMarco; W Miles; M Akhtar; S Milstein; A D Sharma; E Platia; B McGovern; M M Scheinman; W C Govier
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

2.  Insights into atrioventricular nodal function from patients displaying dual conduction properties: interactive and orthogonal pathways.

Authors:  G Stuart Mendenhall; Andrew Voigt; Samir Saba
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-03-08

3.  Adenosine or adenosine triphosphate for supraventricular tachycardias? Comparative double-blind randomized study in patients with spontaneous or inducible arrhythmias.

Authors:  A C Rankin; K G Oldroyd; E Chong; J W Dow; A P Rae; S M Cobbe
Journal:  Am Heart J       Date:  1990-02       Impact factor: 4.749

4.  Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation.

Authors:  Peter M Kistler; Simon P Fynn; Haris Haqqani; Irene H Stevenson; Jitendra K Vohra; Joseph B Morton; Paul B Sparks; Jonathan M Kalman
Journal:  J Am Coll Cardiol       Date:  2005-05-03       Impact factor: 24.094

5.  Atrial tachycardia arising from the coronary sinus musculature: electrophysiological characteristics and long-term outcomes of radiofrequency ablation.

Authors:  Nitish Badhwar; Jonathan M Kalman; Paul B Sparks; Peter M Kistler; Mehran Attari; Marcie Berger; Randall J Lee; Jasbir Sra; Melvin M Scheinman
Journal:  J Am Coll Cardiol       Date:  2005-10-24       Impact factor: 24.094

6.  Induction of atrioventricular node reentrant tachycardia with adenosine: differential effect of adenosine on fast and slow atrioventricular node pathways.

Authors:  A B Curtis; L Belardinelli; D A Woodard; C S Brown; J B Conti
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

7.  The electrophysiologic characteristics in patients with only ventricular-pacing inducible slow-fast form atrioventricular nodal reentrant tachycardia.

Authors:  Pi-Chang Lee; Ching-Tai Tai; Betau Hwang; Ming-Hsiung Hsieh; Chin-Feng Tsai; Chern-En Chiang; Wen-Chung Yu; Hsuan-Ming Taso; Kun-Tai Lee; Yoga Yuniadi; Wanwarang Wongchaoen; Shih-Ann Chen
Journal:  J Interv Card Electrophysiol       Date:  2006-01-18       Impact factor: 1.900

8.  Incidence and clinical significance of inducible atrial tachycardia in patients with atrioventricular nodal reentrant tachycardia.

Authors:  C Sticherling; H Tada; R Greenstein; C W Chan; S P Chough; R L Baker; K Wasmer; H Oral; F Pelosi; B P Knight; S A Strickberger; F Morady
Journal:  J Cardiovasc Electrophysiol       Date:  2001-05

9.  Radiofrequency ablation of coronary sinus-dependent atrial flutter guided by fractionated mid-diastolic coronary sinus potentials.

Authors:  Joelci Tonet; Antonio De Sisti; Walid Amara; Robert Frank; Françoise Hidden-Lucet
Journal:  J Interv Card Electrophysiol       Date:  2010-09-04       Impact factor: 1.900

10.  Coexistence of atrioventricular nodal reentrant tachycardia with other forms of arrhythmias.

Authors:  Christiana Schernthaner; Franz Danmayr; Bernhard Strohmer
Journal:  Med Princ Pract       Date:  2014-09-03       Impact factor: 1.927

  10 in total
  1 in total

1.  Change in VA interval by a single atrial premature depolarization - What is the mechanism?

Authors:  Debabrata Bera; Suchit Majumder; Kuntal Bhattacharya; Sanjeev S Mukherjee
Journal:  Indian Pacing Electrophysiol J       Date:  2021-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.